Close Menu X
Kelley & Ferraro, LLP
Free Consultations ~ Practicing Nationwide
216-202-3450 800-398-1795

Food and Drug Administration issues recall of dietary supplement

Many Ohio residents take dietary supplements for a variety of reasons. Part of the problem with the supplements is that they do not undergo testing necessarily undergo the same scrutiny by the Food and Drug Administration as prescribed medications do, which means they are often classified as unapproved drugs, especially if they contain medications ordinarily prescribed by doctors. The recent recall of a dietary supplement claiming to help with libido occurred because it contained an unapproved drug.

The Med Man supplement, called Up2, was found to contain sildenafil, which is prescribed for erectile dysfunction. This medication may be approved by the FDA for prescription by a doctor, but not for use in this dietary supplement. Part of the reason for this is that there could be dangerous drug interaction issues. For example, those who take nitrates, such as nitroglycerin, could experience life-threatening low blood pressure when taking the recalled supplement and these medications.

Anyone with diabetes, heart disease, high cholesterol or high blood pressure are at risk if they take nitrates and this product. For this reason, all lots of the product are to be removed from the market and destroyed. At the time of the recall, no reports of adverse health events were reported.

However, that does not mean that the Food and Drug Administration and the company will get the word out in time. Before all of the dietary supplement is removed from the market, someone could end up suffering harm from its use. If that happens, that individual, or his or her family in the event of death, could pursue restitution through the filing of pharmaceutical litigation in an Ohio civil court.

No Comments

Leave a comment
Comment Information

Awards & Recognition

Contact Us For A Free Case Evaluation

Bold labels are required.

Contact Information

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.


Privacy Policy

Email Us For A Response